Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

PROVE, our clinical trial on Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture is currently recruiting participants from 13 centres across England, with an additional five centres being set up.

PROVE, our clinical trial on Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture is currently recruiting participants from 13 centres across England, with an additional five centres being set up.

The study has been running for just over a year and aims to discover if physiotherapy can improve life quality and mobility for patients recovering from spine fractures related to their osteoporosis by comparing usual care vs. an exercise based intervention vs. a manual therapy based intervention; it will also look at the cost-effectiveness of offering physiotherapy as a care package.

Each year, 120,000 osteoporosis-related spine fractures occur in the UK; 40 % of patients diagnosed with a vertebral fracture will have constant pain and the majority will have difficulties with activities of daily living. Many of these patients are referred for physiotherapy to help with recovery, but we do not know which type of physiotherapy is most helpful to people.

Lead researcher Dr Karen Barker, of NDORMS and Clinical Director (Musculoskeletal) & Head of Physiotherapy at the Nuffield Orthopaedic Centre says of the study:  “We know that suitable physiotherapy can have a significant impact at improving patients’ function and quality of life. The incidence of osteoporosis and associated spinal problems will continue to increase as our population ages and it is vital that we develop effective treatment strategies to help those patients in pain from this disease. Already, PROVE is the largest physiotherapy trial in osteoporosis and on completion of the trial we are confident we will be in a position to advise patients, clinicians and health care commissioners on the place of physiotherapy in osteoporosis management.”

PROVE is led by the University of Oxford and funded by the NIHR HTA (National Institute of Health Research Health Technology Assessment).

You can read more about PROVE on their website. If you are interested in participating and finding out more about this trial please send an email to prove@ndorms.ox.ac.uk or call 01865223489.

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.